Salarat, Baby Boy .

HRN: 23-52-54  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/12/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/12/2023
08/19/2023
IV
520mg
Q6hours
Sepsis Sec To AGE With Severe Degydration
Waiting Final Action 

Indication:  Empiric    Type of Infection:  BloodstreamIntra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: